PDE isoforms inhibitors have already been used in the treatment of asthma, chronic obstructive pulmonary disease, pulmonary hypertension and multiple sclerosis (Houslay et al., 2005; Naviglio et al., 2009), demonstrating that this class of drugs might be safe for human use. This evidence concerns the gene ALDH7A1 and pulmonary hypertension.